Table 1 Prevalence of use (‰) of the 31 most common pharmacological groups in 2012 in Italy
From: Differences in drug use between men and women: an Italian cross sectional study
ATC III | Description | Prevalence (‰) | Crude Relative Risk | Adjusted Relative Risk | |
|---|---|---|---|---|---|
Male | Female | ||||
A02B | Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 164,1 | 128,2 | 1,3 | 1,1 |
A10A | Insulins and analogues | 10,5 | 10,9 | 1,0 | 0,8 |
A10B | Blood glucose lowering drugs, excluding insulins | 45,7 | 50,6 | 0,9 | 0,8 |
A12A | Calcium | 24,3 | 2,8 | 8,6 | 7,0 |
B01A | Antithrombotic agents | 106,5 | 113,9 | 0,9 | 0,7 |
B03A | Iron preparations | 10,1 | 3,8 | 2,6 | 2,1 |
B03B | Vitamin B12 and folic acid | 7,0 | 3,7 | 1,9 | 1,6 |
C01B | Antiarrhythmics, class I and III | 10,1 | 10,6 | 1,0 | 0,7 |
C01D | Vasodilators used in cardiac diseases | 14,5 | 15,0 | 1,0 | 0,7 |
C02C | Antiadrenergic agents, peripherally acting | 11,9 | 13,4 | 0,9 | 0,7 |
C03C | High-ceiling diuretics | 34,0 | 26,4 | 1,3 | 0,9 |
C07A | Beta blocking agents | 84,8 | 72,1 | 1,2 | 1,0 |
C08C | Selective calcium channel blockers with mainly vascular effects | 52,6 | 57,7 | 0,9 | 0,7 |
C09A | ACE inhibitors, plain | 58,6 | 70,2 | 0,8 | 0,7 |
C09B | ACE inhibitors, combinations | 44,7 | 36,1 | 1,2 | 1,0 |
C09C | Angiotensin II antagonists, plain | 49,0 | 46,8 | 1,1 | 0,9 |
C09D | Angiotensin II antagonists, combinations | 62,1 | 46,3 | 1,4 | 1,1 |
C10A | Lipid modifying agents, plain | 91,4 | 97,8 | 0,9 | 0,8 |
G04C | Drugs used in benign prostatic hypertrophy | 0,2 | 61,9 | 0,0 | 0,0 |
H02A | Corticosteroids for systemic use, plain | 32,9 | 23,2 | 1,4 | 1,3 |
H03A | Thyroid preparations | 64,8 | 12,0 | 5,4 | 5,0 |
J01C | Beta-lactam antibacterials, penicillins | 71,2 | 53,4 | 1,3 | 1,3 |
M01A | Anti-inflammatory and antirheumatic products, non-steroids | 124,5 | 73,9 | 1,7 | 1,5 |
M04A | Antigout preparations | 11,5 | 20,9 | 0,6 | 0,4 |
M05B | Drugs affecting bone structure and mineralization | 31,7 | 2,0 | 16,0 | 12,5 |
N03A | Antiepileptics | 21,6 | 18,7 | 1,2 | 1,1 |
N06A | Antidepressant | 68,0 | 29,5 | 2,3 | 2,0 |
R03A | Adrenergics, inhalants | 30,3 | 33,3 | 0,9 | 0,8 |
R03B | Other drugs for obstructive airway diseases, inhalants | 27,6 | 28,6 | 1,0 | 0,8 |
R06A | Antihistamines for systemic use | 26,4 | 20,8 | 1,3 | 1,3 |
S01E | Antiglaucoma preparations and miotics | 21,2 | 17,0 | 1,3 | 1,0 |